Relmada Therapeutics Inc
NASDAQ:RLMD 2:39:35 PM EDT
Earnings Announcements
Relmada Therapeutics Reports Fourth Quarter Results
Published: 03/23/2022 20:29 GMT
Relmada Therapeutics Inc (RLMD) - Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-year 2021 Financial Results.
Q4 Loss per Share $1.80.
Q4 Earnings per Share View $-1.83 -- Refinitiv Ibes Data (analyst estimates).
Q4 Loss per Share $1.80.
Q4 Earnings per Share View $-1.83 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.27
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.27
More details on our Analysts Page.
Adjusted EPS is expected to be -$1.27
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.27
More details on our Analysts Page.